0001179110-17-009159.txt : 20170616 0001179110-17-009159.hdr.sgml : 20170616 20170616092805 ACCESSION NUMBER: 0001179110-17-009159 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170615 FILED AS OF DATE: 20170616 DATE AS OF CHANGE: 20170616 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PEPIN RONALD CENTRAL INDEX KEY: 0001214504 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 17914935 MAIL ADDRESS: STREET 1: MEDAREX STREET 2: 707 STATE ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 edgar.xml FORM 4 - X0306 4 2017-06-15 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001214504 PEPIN RONALD C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD HAMPTON NJ 08827 0 1 0 0 Sr. VP & CBO Incentive Stock Option (right to buy) 2.32 2017-06-15 4 A 0 67000 0.00 A 2018-06-15 2027-06-15 Common Stock 67000 67000 D Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan. 25% vest on June 15, 2018 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. /s/ Avery W. Catlin, attorney in fact for Ronald A. Pepin, Ph.D. 2017-06-16